At this year’s American Association for Cancer Research® (AACR) Annual Meeting 2026 in San Diego on April 17-22, Biognosys Group will have a strong presence with 8 scientific posters and an immersive booth experience.
We are excited to meet you at our poster presentations and booth #2351.
More information to follow soon.
Our team of experts is looking forward to greeting you at booth #2351 and discussing with you the latest on our solutions for oncology research.
Exhibit Dates and Times
Book an on-site meeting with one of our experts to explore how we could address your research needs.
TrueDiscovery is the only platform that searches the complete proteome to quantify thousands of the most relevant proteins, including an unlimited number of proteoforms. [...]
The Biognosys TrueSignature platform provides customizable proteomics panels for pharmacodynamic readouts and clinical biomarker monitoring with exceptional precision.
TrueTarget is a platform that uniquely addresses the most pressing challenges in early drug discovery by identifying on- and off-targets to accelerate and de-risk drug de [...]
The BeatBox is a fast and easy to use instrument for up to 96 samples, which completes the homogenization in as little as 10 minutes without sample cross contamination an [...]
The integration of Biognosys’ P2 single particle technology with PreOmics’ proven iST workflow introduces a next-generation, particle-based enrichment solution that i [...]
MxP Quant 1000 delivers groundbreaking coverage of biomarkers in a single kit, setting a new standard of excellence for in quantitative metabolomics profiling. High analy [...]
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 244 50 00
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
